Amgen (AMGN) and AstraZeneca (AZN) have agreed to collaborate on the development and...

|About: Amgen Inc. (AMGN)|By:, SA News Editor

Amgen (AMGN) and AstraZeneca (AZN) have agreed to collaborate on the development and commercialization of 5 drugs in Amgen's clinical inflammation porfolio. AstraZeneca will lead the way in developing 3 of the 5 drugs.  AstraZeneca will make a $50M one-time payment to Amgen, as well as royalty payments following commercialization.